Study to Evaluate Adverse Events, Change in Disease Activity, and How Intravenously Infused ABBV-291 Moves Through the Body in Adult Participants With Non-Hodgkin's Lymphoma
Clinical trial NCT06667687 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06667687
- Sponsor
- AbbVie
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-16
- Primary completion
- 2027-04-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.